MANCHESTER, England, Feb. 16, 2016— 2016 is an exciting year for Excellis Health Solutions. As the leading provider of Life Sciences and Healthcare consulting services, Excellis is eager to reveal the recent acquisition of 3C Integrity, a specialized pharmaceutical consulting company based out of Manchester, UK.
3C Integrity is run by professional experts with many years of designing and implementing product security and serialization solutions in the pharmaceutical supply chain industry. With unique Subject Matter Expertise and Strategic Pharma Consulting, the creation of 3C Excellis Europe will produce exceptional breakthrough results which bring long-term value to customers. One of 3C Excellis Europe’s recent success includes the recent involvement in EMVO, the European Medicines Verification Organisation.
Excellis Health Solutions plans to draw in 3C Integrity’s strengths and best practices to provide world-leading expert consultancy focused on the challenges within the pharmaceutical supply chain industry.
This procurement will enable 3C Excellis Europe to develop new products helping pharmaceutical supply chain clients in many existing expertise areas including: ERP, Supply Chain, and Manufacturing. We will pull from our comprehensive industry knowledge and proven turnkey solutions to efficiently meet our clients’ needs.
By joining forces, Excellis Health Solutions will be able to increase capacity, focus on additional expertise and knowledge, and offer a multitude of services to pharma manufactures, CMOs and repackagers as well as to distributors and wholesalers in the pharmaceutical and life-science industries.
“As often requested by our customers in Europe, we are now in a position to offer a complete set of services. This is a strategic move that will strengthen our position as a life science supply chain leader Europe.”
3C Excellis Europe will become a subsidiary of Excellis Health Solutions, incorporating the current Excellis Europe organization. Frederic Menardo, Excellis Health solutions VP EMEA, with former leadership positions across Europe at Johnson and Johnson, will join the 3C Excellis Europe management team alongside Christoph Krahenbuhl and Ian Haynes, former AstraZeneca executives.
“As the pharmaceutical and medical devices industry stakeholders are facing many challenges in securing their brand and addressing the different serialization mandates this puts Excellis in a unique position to offer a full range of actionable strategic services.”
-Greg Cathcart, CEO of Excellis Health Solutions.
NOTE: Excellis Health Solutions and the Excellis Health Solutions logos are trademarks of Excellis Health Solutions, LLC. in the United States and other countries. All other company and product names mentioned are the trademarks or registered trademarks of their respective companies.
Check out the official link here.